For the study, 76 mild-to-moderate dementia patients received either a placebo, ginkgo or Aricept for six months, followed by a four-week course of a placebo to exclude those reactions.
During the study period, more ginkgo patients dropped out of the test, but not for the same reasons as the four Aricept dropouts, who left due to adverse drug reactions.Based on test scores to determine the severity of dementia afterward, scientists agreed both ginkgo biloba and Aricept work just as effectively to slow down the damage.
The effects of ginkgo biloba on dementia have been demonstrated many times before. In 1997, the very first year of my newsletter, I posted a study from JAMA that showed clear evidence that Ginkgo is helpful in the treatment of Alzheimer's disease.
But this new study is yet another sign that conventional medicine is finally starting to acknowledge and appreciate all the benefits alternative treatments provide.
I wonder, however, if the beneficial effects of Aricept on study patients was a statistical aberration, or product of a serious conflict of interested researcher, considering cholinesterase inhibitors like Aricept, Reminyl and Exelon have been found to be beneficial for only 20 percent of Alzheimer's patients.
Alzheimer's is a sad and devastating disease. It is expected to triple over the next generation, so it will undoubtedly be a huge problem worldwide -- one that is far easier to prevent than to treat.
Fortunately, with Alzheimer's you do have some options. Ginkgo is merely one of several natural, safer treatments to beat Alzheimer's. Some of the rest include:
In the Vital Votes section, Chip Engelmann, a nutrionist from the town of Indiana, Pennsylvania, has some interesting comments. While I agree with them I have yet to find a glyconutrient that was not sold from a multi-level company. I do not agree with that form of distribution and could never advocate anyone purchase them because of the seriously inflated prices: